Graft-versus-host Disease
📧 Sign up to get email alerts when something new happens for Graft-versus-host Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: A Preliminary Clinical Study on the Efficacy of Cyclophosphamide and Sirolimus Combined With VIC-1911 in Preventing Graft-versus-Host Disease After Haploidentical Stem Cell Transplantation in Children [Phase 1]
Phase 1 study evaluating the efficacy of combining cyclophosphamide, sirolimus, and VIC-1911 to prevent graft-versus-host disease after hapl…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Multidisciplinary Intervention In Chronic GVHD [NA]
This clinical trial update notes an ongoing multidisciplinary intervention for chronic graft-versus-host disease, focusing on coping skills …
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: Metabolome and Microbiome Impact on Acute GVHD in Recipients of Hematopoietic Transplant
A clinical trial examining how the metabolome and microbiome influence acute graft-versus-host disease in recipients of hematopoietic stem c…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: Novel First-line Therapies for Grade II Acute GVHD(Graft-versus-host Disease ) [Phase 2]
A Phase 2 clinical trial evaluating novel first-line therapies for Grade II acute graft-versus-host disease in stem cell transplant patients…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: Fecal Microbiota Transplantation for the Prevention of Acute Graft Versus Host Disease in Adults Undergoing Allogeneic Hematopoietic Cell Transplantation [Phase 2]
Phase 2 clinical trial evaluating fecal microbiota transplantation to prevent acute graft-versus-host disease in adults undergoing allogenei…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Development of a Multi-biomarker Panel for Prognostic Stratification and Treatment Response Prediction in Acute Graft Versus Host Disease of the Gut
A clinical trial update describing the development of a multi-biomarker panel to prognosticate outcomes and predict treatment response in ac…
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: Ustekinumab for the Prevention of Acute Graft-versus-Host Disease After Unrelated Donor Hematopoietic Cell Transplant [Phase 2]
Phase 2 clinical trial evaluating ustekinumab for prevention of acute graft-versus-host disease in patients undergoing unrelated donor hemat…
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: Psychiatric Status and Symptom Severity in Graft-versus-Host Disease (GvHD).
This clinical trial update investigates psychiatric status and symptom severity in chronic graft-versus-host disease and is currently recrui…
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: Effect of Stem Cell Infusion Time on aGVHD in Patients With Hematological Malignancies [Phase 3]
Phase 3 clinical trial evaluating whether the timing of stem cell infusion affects the development of acute graft-versus-host disease in pat…
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: Relationship Between "FODMAPs" and "GVHD"
A clinical trial is evaluating the relationship between dietary FODMAPs and graft-versus-host disease, and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: Efficacy and Safety of Auto-FMT in Preventing aGVHD [NA]
The document reports a clinical trial evaluating autologous fecal microbiota transplantation (Auto-FMT) for preventing acute graft-versus-ho…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: A Study to Evaluate Adrixetinib (Q702) in Adults With Active Chronic Graft-Versus-Host Disease [Phase 1]
Clinical trial update outlining a Phase 1 study of Adrixetinib (Q702) in adults with active chronic graft-versus-host disease, currently rec…
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: Optimizing PTCy Dose and Timing [Phase 1, Phase 2]
This clinical trial update describes an ongoing Phase 1/2 study aiming to optimize the dose and timing of post-transplant cyclophosphamide t…
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: Ibrutinib for the Prevention of Chronic Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant [Phase 2]
A Phase 2 clinical trial is evaluating ibrutinib for prevention of chronic graft-versus-host disease in patients receiving donor stem cell t…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Effect of Stem Cell Infusion Time on aGVHD in Patients With Hematological Malignancies Post UCBT [Phase 3]
Phase 3 clinical trial evaluating whether different stem cell infusion times affect the incidence of acute graft-versus-host disease after u…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Framework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALL [Phase 2, Phase 3]
This study outlines a framework to optimize, refine, and unify management of hematopoietic stem cell transplantation in pediatric acute lymp…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Electrostimulation Study for Ocular Graft vs. Host Disease [NA]
Clinical trial update describing an electrostimulation study for chronic ocular graft-versus-host disease. The study is currently recruiting…
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: First-Line Jaktinib for Acute Graft-Versus-Host Disease (aGVHD) [Phase 1, Phase 2]
This is a clinical trial update on first-line jaktinib for acute graft-versus-host disease. The study is in Phase 1/Phase 2 and currently re…
-
CLINICAL_TRIALS research · 2025-12-15Clinical Trial Update: A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD) [Phase 2]
A Phase 2 study evaluating Vimseltinib in adults with active chronic graft-versus-host disease is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-15Clinical Trial Update: Optimizing GVHD Prophylaxis After Allogeneic Hematopoietic Cell Transplantation [Phase 2]
Phase 2 clinical trial registration to optimize graft-versus-host disease prophylaxis after allogeneic hematopoietic cell transplantation. T…
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Evaluation of Rovadicitinib Compared to the Protocol Selected by Researchers in Third Line and Subsequent Studies of Moderate to Severe Chronic Graft-versus-host Disease [Phase 3]
Clinical trial update indicating a Phase 3 study evaluating Rovadicitinib for moderate-to-severe chronic graft-versus-host disease, with rec…
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: A Study of CYP-001 in Combination With Corticosteroids in Adults With High-risk aGvHD [Phase 2]
Phase 2 clinical trial of CYP-001 in combination with corticosteroids for adults with high-risk acute graft-versus-host disease is currently…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Fecal Microbiota Transplantation in aGvHD After ASCT [Phase 3]
This Phase 3 clinical trial, sponsored by the Medical University of Graz, is evaluating fecal microbiota transplantation for acute graft-ver…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: Study of Efficacy and Safety of Ruxolitinib in Chinese Participants With Corticosteroid-refractory Chronic Graft vs. Host Disease [Phase 4]
Phase 4 clinical trial update evaluating efficacy and safety of ruxolitinib in Chinese participants with corticosteroid-refractory chronic g…
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: Study of Efficacy and Safety of Ruxolitinib in Patients With Grade II to IV Steroid-refractory Acute Graft vs. Host Disease [Phase 4]
Phase 4 clinical trial assessing the efficacy and safety of ruxolitinib in adults with grade II-IV steroid-refractory acute graft-versus-hos…